最新ニュース Under Armour (NYSE:UAA) 株価情報

Under Armour

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

Under Armour Inc

BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) lowers FY2025 sales outlook from $1.81 billion-$2.35 billion to $1.79 billion-$2.31 billion vs $2.08 billion estimate.

News

Guidance

BNTX

BioNTech Lowers FY2025 Sales Guidance from $1.81B-$2.35B to $1.79B-$2.31B vs $2.08B Est

International Game Technology PLC ("IGT") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) announced today that IGT PlaySports&#x2122; technology is now powering retail sports betting at Silver Reef Casino Resort in Ferndale, Wash. This technology agreement builds on IGT PlaySports' leadership in the region, marking the 11th casino in Washington State to deploy the Company's award-winning sports betting platform, and the 10th casino in the State to leverage its trading advisory services.

IGT Powers Retail Sports Betting at Silver Reef Casino, Expanding Presence in Washington State

BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) reported quarterly losses of $(1.82) per share which beat the analyst consensus estimate of $(2.02) by 9.9 percent. This is a 28.17 percent decrease over losses of $(1.42) per share from the same period last year. The company reported quarterly sales of $192.23 million which beat the analyst consensus estimate of $177.40 million by 8.36 percent. This is a 5.65 percent decrease over sales of $203.74 million the same period last year.

Earnings

Earnings Beats

BioNTech Q1 EPS $(1.82) Beats $(2.02) Estimate, Sales $192.23M Beat $177.40M Estimate

HC Wainwright &amp; Co. analyst Robert Burns reiterates ORIC Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIC#NASDAQ">ORIC</a>) with a Buy and maintains $21 price target.

Price Target

Reiteration

Analyst Ratings

ORIC

HC Wainwright & Co. Reiterates Buy on ORIC Pharmaceuticals, Maintains $21 Price Target

HC Wainwright &amp; Co. analyst Robert Burns reiterates Prelude Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) with a Buy and maintains $5 price target.

PRLD

HC Wainwright & Co. Reiterates Buy on Prelude Therapeutics, Maintains $5 Price Target

Benchmark analyst David Williams reiterates Belden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDC#NYSE">BDC</a>) with a Buy and maintains $120 price target.

Benchmark Reiterates Buy on Belden, Maintains $120 Price Target

Stephens &amp; Co. analyst Jim Salera reiterates Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) with a Equal-Weight and maintains $14 price target.

Stephens & Co. Reiterates Equal-Weight on Wendy's, Maintains $14 Price Target

Management

MODV

Modivcare CFO And Chief Information Officer To Depart Following Transition Period; Co. Will Not Be Replacing These Roles At This Time

Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is a 75.68 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $263.25 million which beat the analyst consensus estimate of $260.12 million by 1.20 percent. This is a 17.60 percent increase over sales of $223.85 million the same period last year.

FRPT

Freshpet Q1 Adj. EPS $0.09, Inline, Sales $263.25M Beat $260.12M Estimate

GPUS

Hyperscale Data Announces Prelim. Q1 Revenue Surpassing $25M; Sees FY25 Revenue $115M-$125M

Chinese bargain retailer Temu has abruptly stopped shipping products directly from China to U.S. consumers as it confronts President Donald Trump&#8216;s 145% tariffs and the end of a key import loophole that took effect Friday.
What Happened: The e-commerce platform owned by PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) has pivoted to displaying only products shipped from U.S.-based warehouses on its website and app, <a href="https://www.cnbc.com/2025/05/02/temu-halts-shipments-direct-from-china-as-de-minimis-tariff-rule-ends-.html">reported</a> CNBC. 
Items previously shipped directly from China are now labeled &#8220;out of stock,&#8221; marking a dramatic shift for a company that built its U.S. presence on ultra-cheap goods shipped directly from Chinese suppliers.
&#8220;Temu has been actively recruiting U.S. sellers to join the platform,&#8221; a company spokesperson told CNBC. &#8220;The move is designed to help local merchants reach more customers and grow their businesses.&#8221; The spokesperson added that pricing for U.S. shoppers &#8220;remains unchanged.&#8221;
The change follows the expiration of the &#8220;de minimis&#8221; rule, which since 2016 had allowed items worth $800 or less to enter the country duty-free. The provision ended at 12:01 a.m. EDT Friday under an executive order signed by Trump in April. 
Days earlier, Temu had briefly added &#8220;import charges&#8221; ranging from 130% to 150% on China-shipped products, which often exceeded the items&#8217; prices. See also: <a href="https://www.benzinga.com/news/management/25/05/45188605/youve-got-to-check-emotions-at-the-door-warren-buffett-offers-timeless-investing-wisdom-amid-market-turmoil">&#8216;You&#8217;ve Got To Check Emotions At The Door:&#8217; Warren Buffett Offers Timeless Investing Wisdom Amid Market Turmoil</a>
Why It Matters: The new regime imposes 90% duties or $75 per item on Chinese imports, <a href="https://www.benzinga.com/news/retail-sales/25/04/44714336/temu-shein-brace-for-impact-as-trumps-tariff-torpedo-blows-up-the-800-loophole">scheduled to increase</a> to $150 per item by June 2025.
The end of the duty-free loophole affects other retailers too. Shein has raised prices while adding a checkout notice that &#8220;tariffs are included in the price you pay.&#8221; Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Haul, which competed with Temu by offering <a href="https://www.benzinga.com/media/25/04/45086459/amazon-pressures-suppliers-for-discounts-may-show-tariff-related-costs-on-haul-site">products priced at $20 or less shipped from China</a>, is also impacted.
Critics of the de minimis provision have argued it harmed American businesses while facilitating shipments of illicit substances due to reduced customs inspection. Forever 21, <a href="https://www.benzinga.com/news/retail-sales/25/04/44714336/temu-shein-brace-for-impact-as-trumps-tariff-torpedo-blows-up-the-800-loophole">now liquidating stores, previously blamed</a> Temu and Shein&#8217;s ultra-low prices for gutting its customer base, according to court filings reported by Axios.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45188438/think-siri-spied-on-you-iphone-users-are-being-invited-to-claim-share-of-apples-95-million-privacy-lawsuit-settlement">iPhone Users Invited To Claim Share Of Apple&#8217;s $95 Million Privacy Lawsuit Settlement: How To Know If You&#8217;re On The List</a></li>
</ul>
Image Via Shutterstock
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Equities

Government

Regulations

Emerging Markets

Markets

Tech

AMZN

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Amazon Rival PDD Holdings' Temu Halts China To US Shipments Amid Trump's 145% Tariffs: 'Actively Recruiting US Sellers'

Needham analyst Joshua Reilly reiterates Asure Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASUR#NASDAQ">ASUR</a>) with a Buy and maintains $20 price target.

ASUR

Needham Reiterates Buy on Asure Software, Maintains $20 Price Target

IBRX

ImmunityBio Requests Receives Refusal to File Letter From FDA For sBLA For ANKTIVA Plus Bacillus Calmette-Guerin; Co. Requests FDA Meeting To Address Change In Agency's Guidance On Jan. 25

Zimmer Biomet Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) lowers FY2025 Adj EPS guidance from $8.15-$8.35 to $7.90-$8.10 vs $8.19 analyst estimate. Raises FY2025 sales outlook from $7.76 billion-$7.95 billion to $8.12 billion-$8.31 billion vs $7.91 billion estimate.

Zimmer Biomet Holdings Lowers FY2025 Adj EPS Guidance from $8.15-$8.35 to $7.90-$8.10 vs $8.19 Est; Revenue for 2025 FY is expected to up by 5.7% - 8.2% YoY

Needham analyst Mike Cikos reiterates N-able (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NABL#NYSE">NABL</a>) with a Buy and maintains $10 price target.

NABL

Needham Reiterates Buy on N-able, Maintains $10 Price Target

Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $0.10 by 360 percent. This is a 170.27 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $263.25 million which beat the analyst consensus estimate of $260.12 million by 1.20 percent. This is a 17.60 percent increase over sales of $223.85 million the same period last year.

Earnings Misses

Freshpet Q1 EPS $(0.26) Misses $0.10 Estimate, Sales $263.25M Beat $260.12M Estimate

Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) lowers FY2025 sales outlook from $1.18 billion-$1.21 billion to $1.12 billion-$1.15 billion vs $1.18 billion estimate.

Freshpet Lowers FY2025 Sales Guidance from $1.18B-$1.21B to $1.12B-$1.15B vs $1.18B Est

Zimmer Biomet Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) reported quarterly earnings of $1.81 per share which beat the analyst consensus estimate of $1.77 by 2.26 percent. This is a 6.7 percent decrease over earnings of $1.94 per share from the same period last year. The company reported quarterly sales of $1.91 billion which beat the analyst consensus estimate of $1.90 billion by 0.72 percent. This is a 1.06 percent increase over sales of $1.89 billion the same period last year.

Zimmer Biomet Holdings Q1 Adj. EPS $1.81 Beats $1.77 Estimate, Sales $1.91B Beat $1.90B Estimate

Collective Mining Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNL#NYSE">CNL</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CNL#TSX">CNL</a>) ("Collective" or the "Company") is pleased to announce that drilling assay results at the San Antonio Project's Pound target ("Pound") has resulted in the discovery of a mineralized Au-Ag-Cu-Mo porphyry system. Additionally, the final assay results from the 2024 drill program at the Trap target (Guayabales Project) are reported below. Both the San Antonio and Guayabales projects are situated near to each other and to the famous multi-million-ounce Marmato Mine within the Caldas Department in Colombia.
The Company currently has nine drill rigs operating as part of its fully funded 70,000-metre drill program for 2025 with two rigs at the San Antonio Project and seven rigs at the Guayabales Project. Two additional deep capacity rigs are being mobilized to the Guayabales Project and will begin testing the high-grade Ramp Zone located at the bottom of the Apollo system in early Q3, 2025.

TSX:CNL

Collective Mining Discovers New Porphyry System at San Antonio Project, Expands Drilling Program

Park Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>) lowers FY2025 FFO guidance from $1.90-$2.20 to $1.79-$2.09 vs $1.97 analyst estimate..

Comments

Under Armour

ニュース

最新ニュース Under Armour (NYSE:UAA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル